BOSTON SCIENTIFIC ANTICIPATES INTERNATIONAL LAUNCH OF PROMUS EVEROLIMUS-ELUTING CORONARY STENT SYSTEM

Boston Scientific announced plans for the anticipated International launch of its PROMUS Everolimus-Eluting Coronary Stent System. The addition of the PROMUS Stent will expand the Company's drug-eluting stent portfolio to include two distinct drug platforms.
StreetInsider.com